New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Doctors try CRISPR gene editing for cancer, a 1st in the US

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in
Oncology May 17,2024
Doctors try CRISPR gene editing for cancer, a 1st in the US

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in
Oncology May 17,2024
Health insurance premiums dropped? Not so fast

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he
Oncology May 17,2024
Health insurance premiums dropped? Not so fast

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he
Oncology May 17,2024
Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c
Oncology May 17,2024
Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c
Oncology May 17,2024
Effectiveness of a new bladder cancer treatment demonstrated

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar
Oncology May 17,2024
Effectiveness of a new bladder cancer treatment demonstrated

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar
Oncology May 17,2024
Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

by National Cancer Research InstituteCredit: CC0 Public DomainTwenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research
Oncology May 17,2024
Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

Doctors and nurses reluctant to recommend e-cigarettes to cancer patients

by National Cancer Research InstituteCredit: CC0 Public DomainTwenty-nine per cent of health professionals would not recommend e-cigarettes to cancer patients who already smoke, according to research
Oncology May 17,2024
A compound effective against chemotherapy-resistant cancer cells identified

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou
Oncology May 17,2024
A compound effective against chemotherapy-resistant cancer cells identified

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou
Oncology May 17,2024
Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Oncology May 17,2024
Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Oncology May 17,2024
Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

by University of NottinghamCredit: CC0 Public DomainResearchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for ch
Oncology May 17,2024
Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

by University of NottinghamCredit: CC0 Public DomainResearchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for ch
Oncology May 17,2024
Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,
Oncology May 16,2024
Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,
Oncology May 16,2024
Researchers identify mechanism that allow ketamine to act both fast and slow

Researchers identify mechanism that allow ketamine to act both fast and slow

by Northwestern UniversityMultiple doses of ketamine do not increase the activity of immature neurons. Credit:Cellular and Molecular Life Sciences(2024). DOI: 10.1007/s00018-024-05121
Oncology May 16,2024
Researchers identify mechanism that allow ketamine to act both fast and slow

Researchers identify mechanism that allow ketamine to act both fast and slow

by Northwestern UniversityMultiple doses of ketamine do not increase the activity of immature neurons. Credit:Cellular and Molecular Life Sciences(2024). DOI: 10.1007/s00018-024-05121
Oncology May 16,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com